BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31471911)

  • 1. Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders.
    Cervin M; Storch EA; Piacentini J; Birmaher B; Compton SN; Albano AM; Gosch E; Walkup JT; Kendall PC
    J Child Psychol Psychiatry; 2020 Apr; 61(4):492-502. PubMed ID: 31471911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
    Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
    Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
    Walkup JT; Albano AM; Piacentini J; Birmaher B; Compton SN; Sherrill JT; Ginsburg GS; Rynn MA; McCracken J; Waslick B; Iyengar S; March JS; Kendall PC
    N Engl J Med; 2008 Dec; 359(26):2753-66. PubMed ID: 18974308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effectiveness and prediction of treatment outcome in cognitive behavioral therapy and sertraline for late-life anxiety disorders.
    Schuurmans J; Comijs H; Emmelkamp PM; Weijnen IJ; van den Hout M; van Dyck R
    Int Psychogeriatr; 2009 Dec; 21(6):1148-59. PubMed ID: 19860993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic complaints in anxious youth.
    Crawley SA; Caporino NE; Birmaher B; Ginsburg G; Piacentini J; Albano AM; Sherrill J; Sakolsky D; Compton SN; Rynn M; McCracken J; Gosch E; Keeton C; March J; Walkup JT; Kendall PC
    Child Psychiatry Hum Dev; 2014 Aug; 45(4):398-407. PubMed ID: 24129543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
    Piacentini J; Bennett S; Compton SN; Kendall PC; Birmaher B; Albano AM; March J; Sherrill J; Sakolsky D; Ginsburg G; Rynn M; Bergman RL; Gosch E; Waslick B; Iyengar S; McCracken J; Walkup J
    J Am Acad Child Adolesc Psychiatry; 2014 Mar; 53(3):297-310. PubMed ID: 24565357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of child-focused anxiety treatments for parents and family functioning.
    Keeton CP; Ginsburg GS; Drake KL; Sakolsky D; Kendall PC; Birmaher B; Albano AM; March JS; Rynn M; Piacentini J; Walkup JT
    Depress Anxiety; 2013 Sep; 30(9):865-72. PubMed ID: 23390005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results from the Child/Adolescent Anxiety Multimodal Longitudinal Study (CAMELS): Functional outcomes.
    Swan AJ; Kendall PC; Olino T; Ginsburg G; Keeton C; Compton S; Piacentini J; Peris T; Sakolsky D; Birmaher B; Albano AM
    J Consult Clin Psychol; 2018 Sep; 86(9):738-750. PubMed ID: 30138013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.
    Wang Z; Whiteside SPH; Sim L; Farah W; Morrow AS; Alsawas M; Barrionuevo P; Tello M; Asi N; Beuschel B; Daraz L; Almasri J; Zaiem F; Larrea-Mantilla L; Ponce OJ; LeBlanc A; Prokop LJ; Murad MH
    JAMA Pediatr; 2017 Nov; 171(11):1049-1056. PubMed ID: 28859190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of youth anxiety outcomes 3 to 12 years after treatment.
    Makover HB; Kendall PC; Olino T; Carper MM; Albano AM; Piacentini J; Peris T; Langley AK; Gonzalez A; Ginsburg GS; Compton S; Birmaher B; Sakolsky D; Keeton C; Walkup J
    J Anxiety Disord; 2020 Mar; 70():102188. PubMed ID: 32078966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study.
    Kendall PC; Cummings CM; Villabø MA; Narayanan MK; Treadwell K; Birmaher B; Compton S; Piacentini J; Sherrill J; Walkup J; Gosch E; Keeton C; Ginsburg G; Suveg C; Albano AM
    J Consult Clin Psychol; 2016 Jan; 84(1):1-14. PubMed ID: 26460572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Child/Adolescent anxiety multimodal study: evaluating safety.
    Rynn MA; Walkup JT; Compton SN; Sakolsky DJ; Sherrill JT; Shen S; Kendall PC; McCracken J; Albano AM; Piacentini J; Riddle MA; Keeton C; Waslick B; Chrisman A; Iyengar S; March JS; Birmaher B
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):180-90. PubMed ID: 25721183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
    Ginsburg GS; Kendall PC; Sakolsky D; Compton SN; Piacentini J; Albano AM; Walkup JT; Sherrill J; Coffey KA; Rynn MA; Keeton CP; McCracken JT; Bergman L; Iyengar S; Birmaher B; March J
    J Consult Clin Psychol; 2011 Dec; 79(6):806-13. PubMed ID: 22122292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents.
    Caporino NE; Read KL; Shiffrin N; Settipani C; Kendall PC; Compton SN; Sherrill J; Piacentini J; Walkup J; Ginsburg G; Keeton C; Birmaher B; Sakolsky D; Gosch E; Albano AM
    J Clin Child Adolesc Psychol; 2017; 46(5):675-685. PubMed ID: 26467211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults.
    Schuurmans J; Comijs H; Emmelkamp PM; Gundy CM; Weijnen I; van den Hout M; van Dyck R
    Am J Geriatr Psychiatry; 2006 Mar; 14(3):255-63. PubMed ID: 16505130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining CBT and sertraline does not enhance outcomes for anxious youth: a double-blind randomised controlled trial.
    Hudson JL; McLellan LF; Eapen V; Rapee RM; Wuthrich V; Lyneham HJ
    Psychol Med; 2023 Apr; 53(5):1741-1749. PubMed ID: 34463234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of treatment improvement on long-term anxiety: Results from CAMS and CAMELS.
    Crane ME; Norris LA; Frank HE; Klugman J; Ginsburg GS; Keeton C; Albano AM; Piacentini J; Peris TS; Compton SN; Sakolsky D; Birmaher B; Kendall PC
    J Consult Clin Psychol; 2021 Feb; 89(2):126-133. PubMed ID: 33705168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.
    Compton SN; Peris TS; Almirall D; Birmaher B; Sherrill J; Kendall PC; March JS; Gosch EA; Ginsburg GS; Rynn MA; Piacentini JC; McCracken JT; Keeton CP; Suveg CM; Aschenbrand SG; Sakolsky D; Iyengar S; Walkup JT; Albano AM
    J Consult Clin Psychol; 2014 Apr; 82(2):212-24. PubMed ID: 24417601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth.
    Cummings CM; Caporino NE; Settipani CA; Read KL; Compton SN; March J; Sherrill J; Piacentini J; McCracken J; Walkup JT; Ginsburg G; Albano AM; Rynn M; Birmaher B; Sakolsky D; Gosch E; Keeton C; Kendall PC
    J Consult Clin Psychol; 2013 Oct; 81(5):859-64. PubMed ID: 23750468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.